Progesterone and the luteal phase

Estrogen is the main hormone in the first half of the cycle, while progesterone dominates the second half. It rises after ovulation, defines the luteal phase, and is responsible for many of the changes you may experience in the two weeks before your period.

Progesterone receives less attention than estrogen, but its effects reach well beyond the uterus.

Where progesterone comes from

Progesterone is produced almost exclusively by the corpus luteum, the structure that forms from the collapsed follicle after ovulation.

The timeline:

1. Ovulation occurs, and the dominant follicle ruptures and releases the egg
2. The remaining follicle cells transform into the corpus luteum
3. The corpus luteum begins producing progesterone (and some estrogen) within hours
4. Progesterone peaks at approximately days 20–22 of a typical 28-day cycle
5. If no pregnancy occurs, the corpus luteum degenerates around day 26–28
6. Progesterone crashes, and menstruation begins

If pregnancy does occur, the embryo produces hCG (human chorionic gonadotropin), which signals the corpus luteum to keep producing progesterone until the placenta takes over at around 8–12 weeks.

What progesterone does

Progesterone affects the nervous, cardiovascular, and digestive systems as well as the uterus.

Uterine preparation

Progesterone's primary job is to transform the estrogen-primed endometrium into a secretory state ready for potential embryo implantation. It makes the lining thicker, more vascular, and nutrient-rich.

Without adequate progesterone, the endometrium cannot sustain a pregnancy. This is why progesterone supplementation is common in early pregnancy support.

Temperature increase

Progesterone acts on the hypothalamus to raise core body temperature by 0.1–0.5°C. This is the basis of basal body temperature (BBT) tracking and is the temperature shift that Apple Watch wrist sensors detect after ovulation.

The temperature stays elevated for the entire luteal phase and drops when progesterone crashes before menstruation.

Nervous system effects

Progesterone has significant neurological effects:

• Progesterone metabolites, particularly allopregnanolone, have sedative and anxiolytic effects because they enhance GABA receptor activity, the brain's primary inhibitory system
• This GABA enhancement can reduce alertness. It helps explain the sleepiness and fatigue some people experience in the luteal phase, as well as the effect on sleep quality
• The rapid withdrawal of progesterone (and allopregnanolone) before menstruation is implicated in PMS and PMDD mood symptoms

Cardiovascular changes

Progesterone shifts the autonomic nervous system toward sympathetic dominance:

• HRV decreases across the luteal phase
• Resting heart rate increases by 2–5 bpm
• Blood pressure may rise slightly

Wearable devices can measure these changes, which are normal.

Breast changes

Progesterone stimulates development of the milk-producing lobules in breast tissue, which can cause swelling, tenderness, and heaviness during the luteal phase.

Digestive effects

Progesterone relaxes smooth muscle throughout the body, including in the GI tract. This can slow gut motility and contribute to the bloating and constipation some people experience in the luteal phase.

Low progesterone: what it means

Luteal phase deficiency (LPD) refers to inadequate progesterone production during the luteal phase. Possible signs include:

• A luteal phase shorter than 10 days
• Pre-menstrual spotting starting several days before the full period
• Difficulty maintaining early pregnancy
• PMS symptoms appearing unusually early in the luteal phase

Potential causes include:

• Anovulatory or weakly ovulatory cycles. If the follicle does not develop properly, the corpus luteum may be inadequate
• Stress. Cortisol competes with progesterone for resources and can suppress corpus luteum function
• Excessive exercise, particularly when combined with caloric deficit
• Perimenopause. As ovarian function declines, progesterone production becomes less consistent
• Thyroid dysfunction. Hypothyroidism is associated with reduced luteal function

How to detect it

• Track your luteal phase length. If it is consistently under 10 days, progesterone may be insufficient
• Monitor temperature. A weak or short temperature shift suggests lower progesterone
• A blood test can measure serum progesterone 7 days after estimated ovulation (typically day 21 of a 28-day cycle). The level should be above 3 ng/mL for ovulation confirmation and ideally above 10 ng/mL for adequate luteal support

Progesterone and mood: the PMDD connection

For most people, progesterone's GABA-enhancing metabolites have a calming effect. Approximately 3–8% of menstruating individuals, however, have an abnormal sensitivity to these normal progesterone fluctuations. This is the mechanism underlying PMDD (premenstrual dysphoric disorder).

In PMDD, hormone levels are not the problem. The condition involves an abnormal central nervous system response to normal hormonal changes, so hormone-level testing is typically normal in PMDD patients.

Understanding the pattern

Progesterone shapes the luteal phase by raising temperature, shifting autonomic balance, preparing the uterus, and modulating mood. Knowing its role can help explain changes in the second half of the cycle and make an unusual pattern easier to recognize.

---

References

1. Mihm M, Gangooly S, Muttukrishna S. The normal menstrual cycle in women. Animal Reproduction Science. 2011;124(3-4):229-236.
2. Stouffer RL, Hennebold JD. Structure, function, and regulation of the corpus luteum. In: Knobil and Neill's Physiology of Reproduction. 4th ed. 2015:1023-1076.
3. Cole LA. Biological functions of hCG and hCG-related molecules. Reproductive Biology and Endocrinology. 2010;8:102.
4. Gellersen B, Brosens JJ. Cyclic decidualization of the human endometrium in reproductive health and failure. Endocrine Reviews. 2014;35(6):851-905.
5. Cagnacci A, et al. Modification of circadian body temperature rhythm during the luteal menstrual phase. Journal of Applied Physiology. 1996;80(5):1543-1547.
6. Andréen L, et al. Progesterone effects during sequential hormone replacement therapy. European Journal of Endocrinology. 2006;154(1):141-149.
7. Yildirir A, et al. Effects of menstrual cycle on cardiac autonomic innervation. Annals of Noninvasive Electrocardiology. 2002;7(1):60-63.
8. Russo J, Russo IH. Development of the human breast. Maturitas. 2004;49(1):2-15.
9. Wald A, et al. Effect of pregnancy on gastrointestinal transit. Digestive Diseases and Sciences. 1982;27(11):1015-1018.
10. Practice Committee of the American Society for Reproductive Medicine. Current clinical irrelevance of luteal phase deficiency: a committee opinion. Fertility and Sterility. 2015;103(4):e27-e32.
11. Poppe K, Velkeniers B, Glinoer D. The role of thyroid autoimmunity in fertility and pregnancy. Nature Clinical Practice Endocrinology & Metabolism. 2008;4(7):394-405.
12. Jordan J, et al. Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertility and Sterility. 1994;62(1):54-62.
13. Hantsoo L, Epperson CN. Premenstrual dysphoric disorder: epidemiology and treatment. Current Psychiatry Reports. 2015;17(11):87.